# Longjohn Amgen Study - Effect of Denosumab...

> **NCT02444585** · PHASE1 · WITHDRAWN · sponsor: **University of Southern California**

## Conditions studied

- Arthroplasty, Replacement, Hip

## Interventions

- **DRUG:** Denosumab

## Key facts

- **NCT ID:** NCT02444585
- **Lead sponsor:** University of Southern California
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-02-28
- **Primary completion:** 2019-12
- **Final completion:** 2019-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No participants enrolled in the trial
- **Last updated:** 2020-11-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02444585

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02444585, "Longjohn Amgen Study - Effect of Denosumab...". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02444585. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*